GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » Days Payable

Genomma Lab InternacionalB de CV (MEX:LABB) Days Payable : 117.37 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV Days Payable?

Genomma Lab InternacionalB de CV's average Accounts Payable for the three months ended in Mar. 2024 was MXN1,875 Mil. Genomma Lab InternacionalB de CV's Cost of Goods Sold for the three months ended in Mar. 2024 was MXN1,458 Mil. Hence, Genomma Lab InternacionalB de CV's Days Payable for the three months ended in Mar. 2024 was 117.37.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's Days Payable or its related term are showing as below:

MEX:LABB' s Days Payable Range Over the Past 10 Years
Min: 85.53   Med: 105.64   Max: 164.97
Current: 107.99

During the past 13 years, Genomma Lab InternacionalB de CV's highest Days Payable was 164.97. The lowest was 85.53. And the median was 105.64.

MEX:LABB's Days Payable is ranked better than
61.15% of 973 companies
in the Drug Manufacturers industry
Industry Median: 88.69 vs MEX:LABB: 107.99

Genomma Lab InternacionalB de CV's Days Payable increased from Mar. 2023 (95.68) to Mar. 2024 (117.37). It may suggest that Genomma Lab InternacionalB de CV delayed paying its suppliers.


Genomma Lab InternacionalB de CV Days Payable Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Days Payable Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 144.56 121.82 95.02 88.56 103.77

Genomma Lab InternacionalB de CV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.68 92.87 106.84 123.71 117.37

Competitive Comparison of Genomma Lab InternacionalB de CV's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Days Payable distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Days Payable falls into.



Genomma Lab InternacionalB de CV Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Genomma Lab InternacionalB de CV's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (1790.38 + 1839.397) / 2 ) / 6383.9*365
=1814.8885 / 6383.9*365
=103.77

Genomma Lab InternacionalB de CV's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (1839.397 + 1910.354) / 2 ) / 1457.649*365 / 4
=1874.8755 / 1457.649*365 / 4
=117.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomma Lab InternacionalB de CV Days Payable Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV (MEX:LABB) Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV (MEX:LABB) Headlines

No Headlines